Tocilizumab Treatment in Patients With COVID-19

Clinical Trial ID NCT04363853

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04363853

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020 10.13
2 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 6.59
3 The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012 3.18
4 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020 2.03
5 Short term outcome and risk factors for mortality in adults with critical severe acute respiratory syndrome (SARS). J Huazhong Univ Sci Technolog Med Sci 2004 0.75
6 Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017 0.75
Next 100